General Information of Drug (ID: DMMYU5T)

Drug Name
Recombinant human relaxin
Indication
Disease Entry ICD 11 Status REF
Scleroderma 4A42 Phase 2 [1]
Cross-matching ID
TTD ID
D0BA7K

References

1 ClinicalTrials.gov (NCT00406575) Recombinant Human Relaxin for the Treatment of Decompensated CHF. U.S. National Institutes of Health.